Sirtuin 4 knockout exacerbates cardiac injury in septic cardiomyopathy via activating the MAPK-JNK pathway
- 1Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016 China
- 2Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, 215000 China
Abstract
Background: Septic cardiomyopathy (SCM) significantly contributes to mortality among septic patients, and its mechanism is closely related to abnormal inflammatory responses. Previous studies revealed the essential role of the Sirtuin4 gene in cardiomyocyte and myocardial function; however, the precise mechanisms underlying its involvement in SCM remain poorly understood.
Methods: Sepsis model was established by cecal ligation and puncture (CLP) in vivo. Survival rate and sepsis score were assessed. Myocardial function was evaluated by echocardiography, serum creatine kinase isoenzyme (CK-MB) concentration and TUNEL staining. In vitro, mouse cardiomyocytes HL-1 cell line was stimulated with lipopolysaccharide (LPS) to simulate an inflammatory environment. Transcriptomic sequencing identified differentially expressed genes (DEGs) and enriched signaling pathways in hearts from SIRT4-knockout CLP mice, and validated by Western blot and immunofluorescence.
Results: The expression of SIRT4 was significantly downregulated in both CLP-induced myocardium and LPS-treated HL-1 cells. SIRT4 knockout exacerbated CLP-induced mortality and myocardial dysfunction. Furthermore, transcriptomic and molecular biology experiments revealed that SIRT4 deficiency sharply activated the MAPK-JNK pathway. In vitro experiments further validated that SIRT4 knockdown aggravated LPS-induced inflammation in cardiomyocytes by activating the MAPK-JNK pathway. Conversely, inhibiting JNK effectively attenuated both the MAPK-JNK pathway activation and the cellular damage caused by SIRT4 deficiency. Additionally, SIRT4 deficiency activated the mediator AMPK, thereby upregulating the MAPK-JNK pathway in SCM.
Conclusion: SIRT4 knockout exacerbates cardiac injury in septic cardiomyopathy by activating the MAPK-JNK pathway, suggesting SIRT4 is a potential therapeutic target for sepsis-induced cardiomyopathy.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01586-2.
Related
- SIRT5 deficiency exacerbates sepsis acute renal injury by activating ACSL4/FTH1 axis dependent ferroptosis
- NLRC3 deficiency exacerbates high-fat diet-induced enteric nervous system injury and colonic motility dysfunction in mice via activating NF-κB signaling pathway
- Killer Cell Activating Receptor–Associated Protein Exacerbates Intestinal Inflammation Through Promoting Kynurenine–Aryl Hydrocarbon Receptor–Dependent Neutrophil Activation in Ulcerative Colitis
- Plasminogen Activator Inhibitor‐1 Deficiency Exacerbates Pressure Overload‐Induced Cardiac Hypertrophy in Mice
- Dual cardiac amyloidosis with AL cardiomyopathy and ATTR cardiomyopathy in systemic AL amyloidosis: Recommendation for a myocardial histology-based diagnosis
BibTeX
@article{li2026sirtuin,
title = {{Sirtuin 4 knockout exacerbates cardiac injury in septic cardiomyopathy via activating the MAPK-JNK pathway}},
author = {Na Li and Kangla Liao and Jiaxin Chen and Suxin Luo and An He and Shuting Chang},
journal = {Molecular Medicine},
year = {2026},
month = aug,
doi = {10.1186/s10020-026-01586-2},
url = {https://doi.org/10.1186/s10020-026-01586-2},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Sirtuin 4 knockout exacerbates cardiac injury in septic cardiomyopathy via activating the MAPK-JNK pathway
AU - Na Li
AU - Kangla Liao
AU - Jiaxin Chen
AU - Suxin Luo
AU - An He
AU - Shuting Chang
PY - 2026
DA - 2026/08/11
JO - Molecular Medicine
DO - 10.1186/s10020-026-01586-2
UR - https://doi.org/10.1186/s10020-026-01586-2
AB - Background: Septic cardiomyopathy (SCM) significantly contributes to mortality among septic patients, and its mechanism is closely related to abnormal inflammatory responses. Previous studies revealed the essential role of the Sirtuin4 gene in cardiomyocyte and myocardial function; however, the precise mechanisms underlying its involvement in SCM remain poorly understood. Methods: Sepsis model was established by cecal ligation and puncture (CLP) in vivo. Survival rate and sepsis score were assessed. Myocardial function was evaluated by echocardiography, serum creatine kinase isoenzyme (CK-MB) concentration and TUNEL staining. In vitro, mouse cardiomyocytes HL-1 cell line was stimulated with lipopolysaccharide (LPS) to simulate an inflammatory environment. Transcriptomic sequencing identified differentially expressed genes (DEGs) and enriched signaling pathways in hearts from SIRT4-knockout CLP mice, and validated by Western blot and immunofluorescence. Results: The expression of SIRT4 was significantly downregulated in both CLP-induced myocardium and LPS-treated HL-1 cells. SIRT4 knockout exacerbated CLP-induced mortality and myocardial dysfunction. Furthermore, transcriptomic and molecular biology experiments revealed that SIRT4 deficiency sharply activated the MAPK-JNK pathway. In vitro experiments further validated that SIRT4 knockdown aggravated LPS-induced inflammation in cardiomyocytes by activating the MAPK-JNK pathway. Conversely, inhibiting JNK effectively attenuated both the MAPK-JNK pathway activation and the cellular damage caused by SIRT4 deficiency. Additionally, SIRT4 deficiency activated the mediator AMPK, thereby upregulating the MAPK-JNK pathway in SCM. Conclusion: SIRT4 knockout exacerbates cardiac injury in septic cardiomyopathy by activating the MAPK-JNK pathway, suggesting SIRT4 is a potential therapeutic target for sepsis-induced cardiomyopathy. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01586-2.
SN - 1076-1551
SN - 1528-3658
ER -